Skip to main content
. 2021 Sep 29;21:1020. doi: 10.1186/s12879-021-06678-4

Table 1.

NASBA, PCR and colloidal gold results of clinical samples

EORTC/MSG NASBA PCR Colloidal gold Total
+ + +
Proven cases (n = 10) 10 0 7 3 10 0 10
Probable cases (n = 15) 13 2 9 6 15 0 15
Control group (n = 40) 2 38 8 32 7 33 40
Total 25 40 24 41 32 33 65

EORTC/MSG, European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group